This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Christian-Albrechts-Universitat Zu Kiel, Conaris Research Institute. Active years: 2013-2015.
Company Filing History:
2 out of 18 
1 out of 13 Years Active: 2013-2015
Title: The Innovations of Joachim Grötzinger
Introduction
Joachim Grötzinger is a notable inventor based in Altwittenbek, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules and peptides. With a total of three patents to his name, Grötzinger's work has implications for medical science and therapeutic applications.
Latest Patents
Grötzinger's latest patents include innovative advancements in ciliary neurotrophic factor variants. One patent describes a nucleic acid molecule that encodes a peptide with specific binding properties to the ciliary neurotrophic factor receptor. This peptide binds with lower affinity than the natural ciliary neurotrophic factor to the interleukin-6 receptor. Another patent focuses on chimeric human beta defensins, detailing a nucleic acid molecule that codes for peptides with antimicrobial activity. These inventions showcase his expertise in molecular biology and therapeutic development.
Career Highlights
Throughout his career, Grötzinger has been associated with prestigious institutions such as Christian-Albrechts-Universität zu Kiel. His work at these institutions has allowed him to explore various aspects of biotechnology and contribute to significant research projects. His dedication to innovation in the field has earned him recognition among his peers.
Collaborations
Grötzinger has collaborated with esteemed colleagues, including Stefan Rose-John and Jürgen Scheller